COPD Tied to Increased Risk of Ischemic, Hemorrhagic Stroke

Share this content:
COPD Tied to Increased Risk of Ischemic, Hemorrhagic Stroke
COPD Tied to Increased Risk of Ischemic, Hemorrhagic Stroke

MONDAY, Oct. 12, 2015 (HealthDay News) -- Chronic obstructive pulmonary disease (COPD) is associated with increased risk of all stroke, ischemic stroke, and hemorrhagic stroke, although the risks are attenuated after adjustment for smoking, according to a study published online Sept. 28 in the American Journal of Respiratory and Critical Care Medicine.

Marileen L.P. Portegies, M.D., from the Erasmus Medical Center in Rotterdam, Netherlands, and colleagues examined the correlation between COPD and subtypes of stroke in the general population. A total of 13,115 participants within the prospective population-based Rotterdam Study were followed for occurrence of stroke.

The researchers found that COPD was significantly associated with all stroke (hazard ratio [HR], 1.20; 95 percent confidence interval [CI], 1.00 to 1.43), ischemic stroke (HR, 1.27; 95 percent CI, 1.02 to 1.59), and hemorrhagic stroke (HR, 1.70; 95 percent CI, 1.01 to 2.84), after adjustment for age, age², and sex. Similar effect sizes were seen after adjustment for cardiovascular risk factors. Additional adjustment for smoking attenuated the effect sizes for all stroke (HR, 1.09; 95 percent CI, 0.91 to 1.31), ischemic stroke (HR, 1.13; 95 percent CI, 0.91 to 1.42), and hemorrhagic stroke (HR, 1.53; 95 percent CI, 0.91 to 2.59).

"Our cohort study demonstrated a higher risk of both ischemic and hemorrhagic stroke in subjects with COPD, and revealed the importance of smoking as a shared risk factor," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »